Pain Management Study

A Multi-Center, Non-Comparative, Open-Label Extension Study to Assess the Long Term Safety of Sativex Oromucosal Spray (Sativex, Nabiximols) as Adjunctive Therapy in Patients with Uncontrolled Persistent Chronic Cancer-Related Pain.